<i>Benzo fur</i>y: A new trend in the drug misuse scene

Journal of Applied Toxicology - Tập 39 Số 8 - Trang 1083-1095 - 2019
Rita Roque Bravo1, Helena Carmo1, Félix Carvalho1, Maria de Lourdes Bastos1, Diana Dias da Silva1
1UCIBIO, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy University of Porto Rua Jorge Viterbo Ferreira, 228 Porto 4050-313 Portugal

Tóm tắt

AbstractBenzofurans, also known by users as benzo fury or benzofury, are synthetic phenethylamines and constitute the third most prominent group of new psychoactive substances (NPS). As the use of these substances has been spread as an alternative to the classic illicit psychostimulants, such as amphetamines, their legal status was reviewed, resulting in an utter prohibition of these NPS in many countries worldwide. Herein, the prevalence of abuse, chemistry, biological effects, metabolism, and the potential harms and risky behaviors associated with the abuse of benzofurans are reviewed. The congeners of this group are mainly consumed recreationally at electronic dance music parties, in polydrug abuse settings. Benzofurans preferentially act by disturbing the functioning of serotonergic circuits, which induces their entactogenic and stimulant effects and is the reason behind the considerable number of recent benzo fury‐related deaths. The slight interaction of these drugs with the dopaminergic system justifies the rewarding effects of these drugs. To date, published evidence on the mechanisms of toxicity of benzo fury is very limited but a body of research is now beginning to emerge revealing an alarming public health threat regarding the abuse of these NPS.

Từ khóa


Tài liệu tham khảo

10.1016/j.forsciint.2014.10.016

10.1093/jat/bkw018

Advisory Council on the Misuse of Drugs(2013).Benzofurans: A review of the evidence of use and harm. London: Advisory Council on the Misuse of Drugs. Retrieved from:https://www.gov.uk/government/publications/benzofurans‐a‐review‐of‐the‐evidence‐of‐use‐and‐harm

10.1007/s00414-017-1648-9

10.1007/s00204-012-0815-5

Casale J., 2012, Abbreviations for 5‐ and 6‐(2‐Aminopropyl)‐2,3‐dihydrobenzofuran vs. 5‐ and 6‐(2‐Aminopropyl)benzofuran: A Clarification of “APB” and “APDB.”, Microgram Journal, 9, 46

Casale J., 2011, The characterization of 5‐ and 6‐(2‐aminopropyl)‐2,3‐dihydrobenzofuran, Microgram Journal, 8, 62

10.1016/j.pbb.2016.08.002

10.1007/s13181-013-0306-y

Clemente C. G. Chiappini S. Claridge H. Goodair C. &Loi B.(2012).Deaths involving ‘Benzo Fury’ United Kingdom 2011‐2012. International Centre for Drug Policy St George's University of London. Retrieved from:http://mededlive.co.uk/nps_social/2013/09/deaths‐involving‐benzo‐fury‐united‐kingdom‐2011‐2012/

10.1002/jat.2889

10.1016/j.pnpbp.2013.08.013

10.1016/j.tiv.2013.04.010

10.1007/s00204-014-1412-6

10.1016/j.drugalcdep.2017.07.041

European Monitoring Centre for Drug and Drug Addiction. (2011).Annual report on the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union. Retrieved fromhttp://www.emcdda.europa.eu/publications/annual‐report/2011

10.2131/jts.41.329

10.4155/bio-2017-0191

10.3109/15563650.2015.1033630

10.1016/j.annemergmed.2016.03.042

10.1016/j.ejphar.2012.12.006

10.1002/hup.2302

10.3109/15563650.2014.973115

Kim J. Y., 2018, Simultaneous determination of amphetamine‐related new psychoactive substances in urine by gas chromatography‐mass spectrometry, Journal of Analytical Toxicology, 42, 605, 10.1093/jat/bky037

10.1016/j.forsciint.2018.08.044

10.1002/dta.1955

10.1093/jat/bku131

10.1021/jm00075a027

10.1002/jat.3351

10.1016/j.drugalcdep.2015.10.011

10.1016/j.drugalcdep.2016.02.001

10.1016/j.drugpo.2017.07.010

10.1016/j.jchromb.2016.08.043

10.1016/j.jpba.2017.05.028

10.1111/bph.13128

10.1016/j.pnpbp.2016.11.004

10.1007/s00216-015-9247-4

10.1093/jat/bkx020

10.1093/jat/bkt053

10.1007/s00210-016-1297-4

10.1002/dta.1451

10.1002/rcm.6969

10.1002/elps.201400164

10.1016/j.toxac.2016.12.001

10.1016/j.forsciint.2014.03.013

United Nations Office on Drug and Crime(2017).World Drug Report 2017. Retrieved fromwww.unodc.org/wdr2017

10.1080/15563650.2017.1312002

10.1111/add.13720

10.1007/s00216-015-8552-2

10.1007/s00216-014-8360-0

10.1097/FTD.0000000000000240

10.1016/j.drugalcdep.2015.09.030